Stocktoria

Connect Biopharma Holdings Ltd CNTB

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2021-03-19

Connect Biopharma Holdings Ltd statistics & valuation

Market cap$137.9M
P / B3.3×
Net margin-86687.5%
Return on equity-132.2%
FCF margin-80687.5%
Return on capital-136.8%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-60.00% -86687.50% 202320242025
Gross margin (%)
202320242025
Operating margin (%)
-86.20% -90740.60% 202320242025
Return on equity (%)
-61.20% -17.00% -132.20% 202320242025
Shares outstanding
55.1M 55.3M 56.4M 202320242025
Net debt ($)
202320242025
Share buybacks ($)
202320242025
Return on assets (%)
-48.80% -15.40% -98.90% 202320242025
Free cash flow margin (%)
-93.60% -80687.50% 202320242025
Debt / equity (×)
202320242025
EPS ($)
-$1.13 -$0.28 -$1.00 202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023
Operating margin-90740.6%-86.2%—
Net margin-86687.5%-60.0%—
FCF margin-80687.5%-93.6%—
Return on assets-98.9%-15.4%-48.8%
Return on equity-132.2%-17.0%-61.2%
Current ratio3.7411.464.85

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.